The FDA approves the first test for Corona that is similar to a home pregnancy test


The U.S. Food and Drug Administration released FDA Yesterday, I authorized the emergency use of the first antigen test for Coronavirus, where results can be read directly from the test card, a design similar to some pregnancy tests, this simple design is fast and effective for healthcare providers and patients.

This new Covid 19 antigen test is an important addition to the available tests because results can be read in minutes, directly from the test card, and this means that people will know if they are infected with the virus in the test card. Actual time is approximate due to its simpler design and the large number of tests the company expects to take in the coming months. “

“This new antigen test is an important advance in our fight against the epidemic,” he added.


How does the new test work?

A health care provider wipes a patient’s nose and spins the sample onto a test card with the addition of a test reagent after waiting for 15 minutes, the health care provider reads the results directly from the test card one line indicating a negative result; Two lines indicate a positive result.

Where can it be used?

This test can be used in care settings, such as a doctor’s office, emergency room, or some schools, and this test is licensed for use in patients suspected of having an infection. COVID-19 By their health care provider within seven days of symptoms appearing.

Given the simple nature of this test, it is likely that these tests will be widely available.

And according to the test manufacturer Abbott, It plans to run up to 50 million tests per month in the United States in early October 2020.


Test details

Antigen tests are very specific, but they are not as sensitive as molecular tests. Due to the potential for reduced sensitivity compared to molecular assays, negative results from the antigen test may need to be confirmed with a molecular test before treatment decisions are made. Negative results from antigen testing should be considered in the context of clinical observations, patient history, and epidemiological information.

And she did FDA Issuing permission for emergency use to a company Abbott Diagnostics Scarborough.


Please enter your comment!
Please enter your name here